YM181

    WARNING: This product is for research use only, not for human or veterinary use.

MedKoo CAT#: 464923

CAS#: unknown

Description: YM181 is a proteolysis-target chimera (PROTAC)-based EZH2 degrader. YM181 induced robust cell viability inhibition in diffuse large B-cell lymphoma (DLBCL) and other subtypes of lymphomas, outperforming a clinically used EZH2 inhibitor EPZ6438 (tazemetostat) that was only effective against DLBCL. The EZH2 degrader displayed promising antitumor activities in lymphoma xenografts and patient-derived primary. lymphoma cells. The study demonstrates that EZH2 degraders have better therapeutic activity than EZH2 inhibitors, which may provide a potential anticancer strategy to treat lymphoma.


Chemical Structure

img
YM181
CAS# unknown

Theoretical Analysis

MedKoo Cat#: 464923
Name: YM181
CAS#: unknown
Chemical Formula: C57H73N7O10S
Exact Mass: 1047.514
Molecular Weight: 1048.31
Elemental Analysis: C, 65.31; H, 7.02; N, 9.35; O, 15.26; S, 3.06

Price and Availability

This product is not in stock, which may be available by custom synthesis. For cost-effective reason, minimum order is 1g (price is usually high, lead time is 2~3 months, depending on the technical challenge). Quote less than 1g will not be provided. To request quote, please email to sales @medkoo.com or click below button.
Note: Price will be listed if it is available in the future.

Request quote for custom synthesis

Synonym: YM181; YM 181; YM-181;

IUPAC/Chemical Name: (2S,4R)-1-((S)-2-(2-(2-(2-((3'-(((4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)carbamoyl)-5'-(ethyl(tetrahydro-2H-pyran-4-yl)amino)-4'-methyl-[1,1'-biphenyl]-4-yl)oxy)ethoxy)ethoxy)acetamido)-3,3-dimethylbutanoyl)-4-hydroxy-N-(4-(4-methylthiazol-5-yl)benzyl)pyrrolidine-2-carboxamide

InChi Key: DODCRKMIDHTGAE-RMIMYVLFSA-N

InChi Code: InChI=1S/C57H73N7O10S/c1-9-63(43-18-20-71-21-19-43)48-28-42(27-46(37(48)4)53(67)59-31-47-35(2)26-36(3)61-54(47)68)40-14-16-45(17-15-40)74-25-24-72-22-23-73-33-50(66)62-52(57(6,7)8)56(70)64-32-44(65)29-49(64)55(69)58-30-39-10-12-41(13-11-39)51-38(5)60-34-75-51/h10-17,26-28,34,43-44,49,52,65H,9,18-25,29-33H2,1-8H3,(H,58,69)(H,59,67)(H,61,68)(H,62,66)/t44-,49+,52-/m1/s1

SMILES Code: CC(N1)=CC(C)=C(CNC(C2=CC(C3=CC=C(OCCOCCOCC(N[C@@H](C(C)(C)C)C(N4[C@H](C(NCC5=CC=C(C6=C(C)N=CS6)C=C5)=O)C[C@@H](O)C4)=O)=O)C=C3)=CC(N(CC)C7CCOCC7)=C2C)=O)C1=O

Appearance: Solid powder

Purity: >98% (or refer to the Certificate of Analysis)

Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility: To be determined

Shelf Life: >2 years if stored properly

Drug Formulation: To be determined

Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code: 2934.99.9001

Preparing Stock Solutions

The following data is based on the product molecular weight 1048.31 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.
=
x
x
g/mol

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and SDS / CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Dilution Calculator

Calculate the dilution required to prepare a stock solution.
x
=
x

1: Tu Y, Sun Y, Qiao S, Luo Y, Liu P, Jiang ZX, Hu Y, Wang Z, Huang P, Wen S. Design, Synthesis, and Evaluation of VHL-Based EZH2 Degraders to Enhance Therapeutic Activity against Lymphoma. J Med Chem. 2021 Jul 1. doi: 10.1021/acs.jmedchem.1c00460. Epub ahead of print. PMID: 34196564.